Search

Professional Education
Alzheimer's 5 : Use of Pharmacotherapy for Patients with Major Neurocognitive Disorder
This activity includes video lectures and is the fifth in a series of courses that seek to educate clinicians on standardized screening, evaluation, and disease management of Alzheimer's disease and related dementias. This fifth course focuses on the most frequently used and FDA-approved prescription medications for Alzheimer's disease and dementias, the current research regarding its use, and guidelines for prescribing and discontinuing medication. The program will incorporate cultural values and beliefs when creating and sharing the pharmacological care plan. [1.75 AMA PRA Category 1 Credits™, 1.75 Contact Hours (ANCC)]

Community Investment
We are advocates for the health of the entire community—in and out of the clinical setting.

Jul 23, 2024
Contributing Factors to Medical Malpractice Claims: Study Examines Difference Between No-Payment and Indemnity Claims
Jacqueline Ross, RN, PhD, Coding Director, Department of Patient Safety and Risk Management, The Doctors Company, Part of TDC Group
In November 2023, The Doctors Company released a study on diagnosis-related medical malpractice claims with an indemnity over $1 million. Now, to expand our understanding, we have conducted a new analysis: Do contributing factors differ between malpractice claims with no payment and claims with indemnity payments?

Oct 19, 2023
Interventional Radiology Wrong-Site Procedure: Case Review
Julie Song, MPH, CPHRM, Patient Safety Risk Manager II, The Doctors Company
This case review explores factors contributing to a wrong-site procedure and highlights strategies that can help practitioners mitigate risk and increase safety.

Stay in the Know

Sign up for The Doctor’s Practice.

Our e-newsletter features timely articles, videos, and guides on a range of patient safety topics.

Subscribe